Hyman Steven 4
4 · Cyclerion Therapeutics, Inc. · Filed Dec 4, 2023
Insider Transaction Report
Form 4
Hyman Steven
Director
Transactions
- Award
Common Stock
2023-11-30+20,000→ 20,000 total
Footnotes (1)
- [F1]The Reporting Person was granted 20,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. 2,500 of the shares vest immediately and the remaining 17,500 shares are subject to vesting ratably over a 42-month period, provided that the Reporting Person remains as a director of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.